Drug Use-results survey for Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral Solution

Drug Use-results survey for Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral Solution - Drug Use-results survey for Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral Solution

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015897

Enrollment

1900

Registered

2014-12-15

Start date

2011-05-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderately severe dementia of the Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mild to moderately severe dementia of the Alzheimer's type

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Safety(Adverse drug reactions) Effectiveness (Clinical Global Impression-Improvement scale)	—

Countries

Japan

Contacts

Public ContactHirokazu Shirai

Janssen Pharmaceutical K.K. Safety Risk Management Dept.

hshirai3@ITS.JNJ.com03-4411-5951

Outcome results